Vimarsana
Biggest News Aggregation in the World

Page 31 - Ming Wang News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ming Wang. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ming Wang Today - Breaking & Trending Today

Phanes Therapeutics announces FDA IND clearance for PT217, an anti-DLL3/anti-CD47 bispecific antibody being developed for patients with small cell lung cancer and other neuroendocrine cancers - Vimarsana News

Phanes Therapeutics announces FDA IND clearance for PT217, an anti-DLL3/anti-CD47 bispecific antibody being developed for patients with small cell lung cancer and other neuroendocrine cancers

/PRNewswire/ -- Phanes Therapeutics, Inc. (Phanes), a clinical stage biotech company focused on oncology, announced today that it has received clearance from...

Application of Atomic Force Microscopy in Bitumen Materials - Vimarsana News

Application of Atomic Force Microscopy in Bitumen Materials

Modern microscopic methods such as atomic force microscopy (AFM) have significantly increased our understanding of bitumen microstructure. This article will discuss this topic further, looking at applications and the industry’s future.

The International Design Excellence Awards (IDEA)® 2022 Breaks Records Again, With Most Entries Ever - Vimarsana News

The International Design Excellence Awards (IDEA)® 2022 Breaks Records Again, With Most Entries Ever

Seattle, Washington (PRWEB) September 14, 2022 -- The International Design Excellence Awards (IDEA)® 2022 Ceremony & Gala, held at Benaroya Hall in Seattle,

Source: prweb.com
Handelsbanken Fonder AB Reduces Position in Ambarella, Inc. (NASDAQ:AMBA) - Vimarsana News

Handelsbanken Fonder AB Reduces Position in Ambarella, Inc. (NASDAQ:AMBA)

Handelsbanken Fonder AB cut its position in shares of Ambarella, Inc. (NASDAQ:AMBA – Get Rating) by 15.8% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 5,844 shares of the semiconductor company’s stock after selling 1,100 shares during the period. Handelsbanken Fonder […]

Phanes Therapeutics Announces First Patient Dosed in Phase 1 Study of PT199 for Advanced Solid Tumors - Vimarsana News

Phanes Therapeutics Announces First Patient Dosed in Phase 1 Study of PT199 for Advanced Solid Tumors

/PRNewswire/ -- Phanes Therapeutics, Inc. (Phanes), an emerging leader in innovative discovery research and clinical development in oncology, announced today...